| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |